TY - JOUR T1 - Lymph Node Involvement in Epithelial Ovarian Cancer: Sites and Risk Factors in a Series of 355 Patients JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 1307-1313 LP - 1307-1313 DO - 10.1111/IGC.0b013e3181b8a07c VL - 19 IS - 8 AU - Marion Fournier AU - Eberhard Stoeckle AU - Frédéric Guyon AU - Véronique Brouste AU - Laurence Thomas AU - Gaëtan Macgrogan AU - Anne Floquet Y1 - 2009/11/01 UR - http://ijgc.bmj.com/content/19/8/1307-1313.abstract N2 - Objectives: To perform a cartography of lymph node metastases in epithelial ovarian cancer and to determine predictive factors of lymph node metastases.Method: The charts of 355 patients with epithelial ovarian cancer who underwent lymphadenectomy during a primary (n = 252) or secondary debulking surgery (n = 103) were analyzed. The topography of the lymph node metastases was notified for the whole group according to the stage of the disease, the histological type, and the moment of surgery. In patients who underwent a primary surgery before chemotherapy, independent prognostic variables for the risk of lymph node involvement were tested with a multivariate analysis. Independent prognostic factors were combined to determine risk profiles in individual patients.Results: The main area of the lymph node metastases was para-aortic. Isolated pelvic lymph node involvement was 10%. Three variables independently predicted lymph node invasion: advanced T stage, high-risk histological profile, and metastases.Conclusions: When lymphadenectomy is recommended, systematic lymph node dissections in the aortic and pelvic areas are warranted. An isolated pelvic lymph node assessment, particularly in the early stages, is inappropriate. By combining independent risk factors, a useful tool for individual risk assessment of lymph node involvement could be established, helping to decide whether to perform a lymph node dissection, especially at restaging surgery. ER -